Sriram Sathyanarayanan in

Sriram Sathyanarayanan

Login to view DISC.
Chief Scientific Officer at AIRNA
📍 Cambridge, Massachusetts, United States

Sriram Sathyanarayanan is a seasoned biotech executive and the Chief Scientific Officer at AIRNA. With a Ph.D. from the Indian Institute of Science, he has extensive experience leading preclinical development and translational sciences, notably in pioneering exosome-based therapeutics during his tenure at Codiak BioSciences.

Outside of the lab, Sriram is an avid cyclist dedicated to philanthropy. He participates in long-distance rides, such as the 186-mile Pan-Mass Challenge, to raise significant funds for cancer research and patient care at the Dana-Farber Cancer Institute, combining his passion for cycling with a commitment to scientific innovation.

He is currently training to ride 186 miles over two days to raise money for cancer research.

Read the full overview →
Experience
30 Years
Current Role
Chief Scientific Officer
Job Level
Leadership
Location
Cambridge, Massachusetts, United States
Personality Overview

How Sriram shows up

Communication Style
Decision Approach
Work Preference

Behavioral traits and communication patterns that shape how this person evaluates opportunities, builds trust, and makes decisions in professional settings.

Login to view personality overview.
Priorities

Topics Sriram cares about

RNA Therapeutics
As CSO of AIRNA, he is focused on advancing a new class of RNA editing therapeutics, including moving their AIR-001 candidate into the clinic.
Cancer Research Fundraising
He actively raises funds for cancer research at Dana-Farber Cancer Institute by participating in the demanding Pan-Mass Challenge cycling event.
+5 more topics Login to view topics
Career

Work history

9-2023
Chief Scientific Officer
AIRNA
3-2023
Advisor
Novo Holdings; BiOrigin (Novo Seeds)
6-2021 - 7-2023
Chief Scientific Officer
Codiak BioSciences
1-2020 - 6-2021
Senior Vice President, Pre-clinical Development
Codiak BioSciences
7-2017 - 1-2020
VP Biology and Translational Sciences
Codiak BioSciences
In the press

Media appearances

AIRNA Launches to Develop New Class of RNA Editing Therapeutics for Rare and Common Diseases. Featured in FirstWord Pharma
See now
AIRNA Launches to Develop New Class of RNA Editing Therapeutics for Rare and Common Diseases. Featured in First Word Pharma
+1 more appearances Login to view media
Education
1993 - 1998
Ph.D
Indian Institute of Science (IISc)
1991 - 1993
M.Sc; Arts and Science
PSG College
Social presence
in
Behavioral profile

DISC profile (public)

DISC behavioral profile

Dominance, influence, steadiness, and calculativeness scores with guidance on how this person prefers to communicate and decide.

Login to view DISC.

More profiles

Discover additional public profiles from our index.

Unlock the full playbookSee exactly how to sell to Sriram. Free, 10 seconds.